top of page
poseidon final hero mobile.jpg

Bringing a tidal wave of change to solid tumor immunotherapy

poseidon final hero 1 oclock.jpg

Bringing a tidal wave of change to solid tumor immunotherapy

bi-specific-tcell-engager-technology.jpg

Our Mission

TCE-based immunotherapy has the potential to make waves in solid tumor treatment.

​

Poseidon’s Trident platform holds the potential of better solutions for patients.

peptide-based-solid-tumor-therapy.jpg

Our Science

The Trident T-cell engager (TCE) platform technology is:

  • Modular

  • Conditionally activated

  • Optimized for tumor penetration and retention

  • Has as an improved safety profile due to reduced cytokine production

News and Media

September 14, 2024

Poseidon news coming soon

t-cell-solid-tumor-engager.jpg

POSEIDON

bottom of page